“Epstein‐Barr virus associated smooth muscle tumour as an unusual cause of ureteric graft obstruction in a child”
Authors:
- María Tatiana SzklarzMSMaría Tatiana Szklarz
- Catalina TessiCTCatalina Tessi
- Javier RuizJRJavier Ruiz
- Nicolas Ignacio RosiereNRNicolas Ignacio Rosiere
- Felicitas Lopez ImizcozFIFelicitas Lopez Imizcoz
- Santiago WellerSWSantiago Weller
- Marta Lidia MonteverdeMMMarta Lidia Monteverde
- Juan Pablo CorbettaJCJuan Pablo Corbetta
- 6 August 2021
- journal article
- case report
- Published by Wiley in Pediatric Transplantation
- Vol. 25 (8) , e14109
Abstract
Background: Epstein‐Barr virus (EBV) is a DNA virus with oncogenic potential, especially in immunocompromised patients. EBV can promote smooth muscle proliferation, resulting in EBV‐associated smooth muscle tumors (EBV‐SMT).Methods: We report a case of a 10‐year‐old child with end‐stage renal disease secondary to hypoplastic crossed and fused kidneys who underwent kidney transplantation. EBV serology was unknown for the donor and negative for the recipient; three months after he had a primary EBV infection. Two years after the transplantation, percutaneous nephrostomy was performed because of a drop in the estimated glomerular filtration rate and severe dilatation of the graft. Nephrography showed contrast enhancement of the pelvis of the graft kidney and proximal ureter, with a clear blockage at the level of the mid ureter and no passage towards the bladder. A 1.5‐cm tumor was found causing intraluminal compression of the mid ureter.Results: Complete resection of the tumor and distal ureter was performed leaving a short proximal ureter. A tension‐free uretero‐ureteroanastomoses was achieved using the native ureter. There were no surgical complications. Histologic evaluation showed spindle‐shaped muscle cells, moderate pleomorphism, and inflammatory infiltration. Immunohistochemical staining was positive for muscle‐specific actin. Epstein‐Barr encoding region (EBER) in situ hybridization was positive, confirming the diagnosis of EBV‐associated SMT.Conclusions: EBV–SMT is an exceedingly rare oncological entity that may develop in either the graft or any other organ. The clinical findings are location related. EBV seroconversion following transplantation might be a risk factor for the development of SMT in solid organ recipients.Keywords
This publication has 10 references indexed in Scilit:
- Epstein‐Barr virus‐associated smooth muscle tumors after lung transplantationTransplant Infectious Disease, 2019
- Epstein‐Barr virus associated smooth muscle tumors in solid organ transplant recipients: Incidence over 31 years at a single institution and review of the literatureTransplant Infectious Disease, 2018
- Long‐term follow‐up of post renal transplantation Epstein‐Barr virus‐associated smooth muscle tumors: Report of two cases and review of the literatureTransplant Infectious Disease, 2018
- Epstein-Barr Virus–Associated Smooth Muscle TumorArchives of Pathology & Laboratory Medicine, 2016
- Epstein–Barr virus‐associated smooth muscle tumors in children following solid organ transplantation: A reviewPediatric Transplantation, 2015
- Molecular and Clinicopathological Analysis of Epstein-Barr Virus–Associated Posttransplant Smooth Muscle TumorsAmerican Journal of Transplantation, 2012
- DNA Viruses (CMV, EBV, and the Herpesviruses)Seminars in Respiratory and Critical Care Medicine, 2011
- Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumourThe Lancet Oncology, 2006
- Metachronous Epstein-Barr virus–related smooth muscle tumors in a child after heart transplantation: Case report and review of the literatureJournal of Pediatric Surgery, 2001
- The Association of Epstein–Barr Virus with Smooth-Muscle Tumors Occurring after Organ TransplantationNew England Journal of Medicine, 1995